JPS5562065A - 2-methyldihydropyridine derivative - Google Patents
2-methyldihydropyridine derivativeInfo
- Publication number
- JPS5562065A JPS5562065A JP13053079A JP13053079A JPS5562065A JP S5562065 A JPS5562065 A JP S5562065A JP 13053079 A JP13053079 A JP 13053079A JP 13053079 A JP13053079 A JP 13053079A JP S5562065 A JPS5562065 A JP S5562065A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- nitrophenyl
- hydroxymethyl
- methyldihydropyridine
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
NEW MATERIAL:Compounds of formula I (R1 is phenyl, 3-nitrophenyl, 2-chlorophenyl, 4-pyridyl, etc.; R2 is propyl, 2-chloroethyl, 2-phenoxyethyl, etc; R3 is lower alkyl; R4 is dialkoxymethyl, formyl, hydroxymethyl, cyano) or their medical salts.
EXAMPLE: 6-Hydroxymethyl-5-methoxycarbonyl-2-methyl-4-( 3-nitrophenyl )-1,4- dihydropyridine-3-carboxylic isopropyl ester.
USE: Vasodilator; they are effective on cardiac diseases and hyperpiesia.
PREPARATION: The reaction of a compound of formula II (Ra 2 is R2 other than 2-hydroxyethyl) gives the corresponding compound of formula I.
COPYRIGHT: (C)1980,JPO&Japio
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7839978 | 1978-10-10 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60214152A Division JPS61118366A (en) | 1978-10-10 | 1985-09-26 | Intermediate of 2-methyldihydropyridine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5562065A true JPS5562065A (en) | 1980-05-10 |
JPS6125711B2 JPS6125711B2 (en) | 1986-06-17 |
Family
ID=10500226
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13053079A Granted JPS5562065A (en) | 1978-10-10 | 1979-10-09 | 2-methyldihydropyridine derivative |
JP60214152A Granted JPS61118366A (en) | 1978-10-10 | 1985-09-26 | Intermediate of 2-methyldihydropyridine derivative |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60214152A Granted JPS61118366A (en) | 1978-10-10 | 1985-09-26 | Intermediate of 2-methyldihydropyridine derivative |
Country Status (10)
Country | Link |
---|---|
JP (2) | JPS5562065A (en) |
BE (1) | BE879263A (en) |
CA (1) | CA1117117A (en) |
CH (1) | CH642353A5 (en) |
DE (1) | DE2940833A1 (en) |
FR (1) | FR2438654A1 (en) |
GB (1) | GB2036722B (en) |
IT (1) | IT1125469B (en) |
NL (1) | NL7907482A (en) |
SE (2) | SE446265B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59190968A (en) * | 1983-04-05 | 1984-10-29 | バイエル・アクチエンゲゼルシヤフト | Manufacture of symmetric 1,4-dihydropyridine dicarboxylic acid ester |
JPS6038322A (en) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | Easily soluble solid preparation containing dihydropyridine-a substance |
WO2005097118A1 (en) * | 2004-04-05 | 2005-10-20 | Takeda Pharmaceutical Company Limited | Aldosterone receptor antagonists |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7910521L (en) * | 1979-12-20 | 1981-06-21 | Haessle Ab | NEW 2-METHYL-6-SUBSTITUTED-4- (2,3-DISUBSTITUTED PHENYL) -1,4-DIHYDROPYRIDINE-3,5-DIESTERS WITH HYPOTHESIVE PROPERTIES, AND PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION |
JPS57175164A (en) * | 1981-04-18 | 1982-10-28 | Banyu Pharmaceut Co Ltd | 1,4-dihydropyridine derivative and its preparation |
EP0080220B1 (en) * | 1981-11-17 | 1986-02-19 | FISONS plc | Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals |
ZA83959B (en) * | 1982-03-10 | 1984-09-26 | Sandoz Ltd | 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them |
CH655110A5 (en) * | 1982-09-03 | 1986-03-27 | Otsuka Pharma Co Ltd | CARBOSTYRILE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM. |
GB8412208D0 (en) * | 1984-05-12 | 1984-06-20 | Pfizer Ltd | Quinolone inotropic agents |
GB8431119D0 (en) * | 1984-12-10 | 1985-01-16 | Fujisawa Pharmaceutical Co | Anti-arteriosclerotic composition |
GB8602518D0 (en) * | 1986-02-01 | 1986-03-05 | Wyeth John & Brother Ltd | 1 4-dihydropyridines |
JPS63115890A (en) * | 1986-10-31 | 1988-05-20 | Nippon Shinyaku Co Ltd | 2-substituted 1,4-dihydropyridine derivative |
ATE84714T1 (en) * | 1987-06-12 | 1993-02-15 | American Cyanamid Co | TRANSCUTANEOUS ADMINISTRATION OF PHARMACEUTICALS. |
US5114946A (en) * | 1987-06-12 | 1992-05-19 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
US5045553A (en) * | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
EP0322747B1 (en) * | 1987-12-29 | 1994-03-02 | Fujisawa Pharmaceutical Co., Ltd. | A brain neuron protecting agent containing a dihydropyridine compound |
EP0323604B1 (en) * | 1987-12-29 | 1994-05-11 | Fujisawa Pharmaceutical Co., Ltd. | A venous extensibility improving and cardiac hypertrophy suppressant agent containing a dihydropyridine compound |
CN103951608B (en) * | 2009-08-04 | 2016-04-27 | 喜德生(苏州)医药科技有限公司 | Nilvadipine crystal formation and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
GB1591089A (en) * | 1976-12-17 | 1981-06-10 | Fujisawa Pharmaceutical Co | 1,4-dihydropyridine derivatives and process for preparation thereof |
DE2658183A1 (en) * | 1976-12-22 | 1978-07-06 | Bayer Ag | 2-POSITION SUBSTITUTED 1,4-DIHYDROPYRIDINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS A MEDICINAL PRODUCT |
-
1979
- 1979-09-21 CA CA000336130A patent/CA1117117A/en not_active Expired
- 1979-10-08 FR FR7925007A patent/FR2438654A1/en active Granted
- 1979-10-08 BE BE0/197526A patent/BE879263A/en not_active IP Right Cessation
- 1979-10-09 NL NL7907482A patent/NL7907482A/en active Search and Examination
- 1979-10-09 GB GB7935022A patent/GB2036722B/en not_active Expired
- 1979-10-09 SE SE7908367A patent/SE446265B/en not_active IP Right Cessation
- 1979-10-09 DE DE19792940833 patent/DE2940833A1/en active Granted
- 1979-10-09 IT IT26362/79A patent/IT1125469B/en active Protection Beyond IP Right Term
- 1979-10-09 JP JP13053079A patent/JPS5562065A/en active Granted
- 1979-10-10 CH CH912879A patent/CH642353A5/en not_active IP Right Cessation
-
1984
- 1984-02-09 SE SE8400689A patent/SE446096B/en not_active IP Right Cessation
-
1985
- 1985-09-26 JP JP60214152A patent/JPS61118366A/en active Granted
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59190968A (en) * | 1983-04-05 | 1984-10-29 | バイエル・アクチエンゲゼルシヤフト | Manufacture of symmetric 1,4-dihydropyridine dicarboxylic acid ester |
JPS6038322A (en) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | Easily soluble solid preparation containing dihydropyridine-a substance |
JPH0412245B2 (en) * | 1983-08-11 | 1992-03-04 | Fujisawa Pharmaceutical Co | |
WO2005097118A1 (en) * | 2004-04-05 | 2005-10-20 | Takeda Pharmaceutical Company Limited | Aldosterone receptor antagonists |
Also Published As
Publication number | Publication date |
---|---|
SE8400689D0 (en) | 1984-02-09 |
JPS6143343B2 (en) | 1986-09-26 |
CA1117117A (en) | 1982-01-26 |
SE446265B (en) | 1986-08-25 |
JPS6125711B2 (en) | 1986-06-17 |
BE879263A (en) | 1980-04-08 |
JPS61118366A (en) | 1986-06-05 |
FR2438654A1 (en) | 1980-05-09 |
SE446096B (en) | 1986-08-11 |
NL7907482A (en) | 1980-04-14 |
GB2036722A (en) | 1980-07-02 |
GB2036722B (en) | 1982-12-01 |
IT7926362A0 (en) | 1979-10-09 |
FR2438654B1 (en) | 1983-01-14 |
SE8400689L (en) | 1984-02-09 |
DE2940833A1 (en) | 1980-04-30 |
DE2940833C2 (en) | 1989-01-26 |
IT1125469B (en) | 1986-05-14 |
SE7908367L (en) | 1980-04-11 |
CH642353A5 (en) | 1984-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5562065A (en) | 2-methyldihydropyridine derivative | |
JPS55301A (en) | 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation | |
JPS5540678A (en) | Dihydropyridine derivative | |
JPS5547695A (en) | Pyrazole phosphate, its preparation, and insecticide and miticide | |
JPS5432460A (en) | Cycloalkylidenemethylphenylacetic acid derivative and their preparation | |
IE831889L (en) | Triazole antifungal agents | |
IE840451L (en) | Triazolylpropanols. | |
PL253666A1 (en) | Method of obtaining novel triazole derivatives | |
JPS57200386A (en) | Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts | |
JPS5547656A (en) | 2-(2-substituted aminoethyl)-1,4-dihydropyridine derivative and its derivative | |
ES549298A0 (en) | A PROCEDURE FOR THE PREPARATION OF TRIAZOLE DERIVATIVES | |
JPS5251020A (en) | Compositions for combatting pests and mehod of making the same | |
KR860006442A (en) | Method for preparing dihydropyridine derivative | |
JPS56140989A (en) | 1,4-dihydrophyridine-3,5-dicarboxylic ester derivative or its salt | |
IE832553L (en) | Triazoles | |
DE69221897D1 (en) | PREPARATION OF 2- (PYRIDYL) ETHYL SUBSTITUTED PHOSPHORUS COMPOUNDS | |
JPS5677263A (en) | Preparation of n-substituted imidazole | |
JPS52113970A (en) | Thiadiazoline-type organic phosphates, their preparation, and insectic ide or miticide containing the same | |
IT1102427B (en) | PROCEDURE FOR THE PREPARATION OF A FUNGICIDE COMPOUND BY ALCHILATION REACTION | |
JPS5233627A (en) | Preparation of novel o,o-dialkyl-o-(n-alkoxy-halogeno-acycimidoyl) pho sphates or thionophosphates | |
JPS56166167A (en) | 2-hydroxypropane derivative, its preparation, and its use | |
JPS5278896A (en) | Synthesis of 2-substituted thioadenosines | |
JPS51123823A (en) | A barbituric acid insecticide and tickicide | |
JPS5750972A (en) | Pyridazone derivative, and agricultural and gardening fungicide comprising it as active ingredient | |
JPS51151333A (en) | Compounds using as insecticide and miticide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |